CPPHA - CAS 693288-97-0
Catalog number: 693288-97-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
CPPHA is a selective positive allosteric modulator of mGluR5 receptor. It is thought to act at a novel allosteric site and potentiates mGlu5 responses by a mechanism distinct from that of VU 29.
Canonical SMILES:
1.Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
Zhao Z1, Wisnoski DD, O'Brien JA, Lemaire W, Williams DL Jr, Jacobson MA, Wittman M, Ha SN, Schaffhauser H, Sur C, Pettibone DJ, Duggan ME, Conn PJ, Hartman GD, Lindsley CW. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1386-91. Epub 2006 Dec 3.
This Letter describes, for the first time, the synthesis and SAR, developed through an iterative analog library approach, that led to the discovery of the positive allosteric modulator (PAM) of the metabotropic glutamate receptor mGluR5 CPPHA. Binding to a unique allosteric binding site distinct from other mGluR5 PAMs, CPPHA has been the focus of numerous pharmacology studies by several laboratories.
2.N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y1, Goudet C, Pin JP, Conn PJ. Mol Pharmacol. 2008 Mar;73(3):909-18. Epub 2007 Dec 4.
Recent studies suggest that a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor (mGluRs), mGluR5, termed 4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (VU-29), potentiates mGluR5 responses by actions at a site that is overlapping with the binding site of 2-methyl-6-(phenylethynyl)pyridine (MPEP), a previously identified negative allosteric modulator of this receptor. It is interesting that a structurally distinct PAM, N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA), does not to bind to the MPEP site. We now report that CPPHA potentiates mGluR5 responses by a mechanism that is distinct from that of VU-29. VU-29- and CPPHA-induced potentiation of mGluR5 responses are blocked by a neutral ligand at the MPEP allosteric site termed 5-methyl-2-(phenylethynyl)pyridine (5MPEP). However, increasing concentrations of 5MPEP induce parallel rightward shifts in the VU-29 concentration-response curve, whereas 5MPEP inhibits CPPHA potentiation in a noncompetitive manner.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mGluR Products

CAS 56-85-9 L-Glutamine

(CAS: 56-85-9)

L-Glutamine is one of the 20 amino acids encoded by the standard genetic code.

CAS 1382481-79-9 ML 289

ML 289
(CAS: 1382481-79-9)

ML-289 is a negative allosteric modulator of mGlu3 with IC50 value of 0.66 μM. It displays 15-fold selectivity over mGlu2 and inactivity against mGlu5.1.

CAS 1303993-73-8 CHPG Sodium salt

CHPG Sodium salt
(CAS: 1303993-73-8)

The sodium salt of CHPG, which is the selective metabotropic glutamate 5 (mGlu5) receptor agonist.

CAS 936095-50-0 ACET

(CAS: 936095-50-0)

ACET, a potent and selective GluR5-containing kainate receptor antagonist, has been found to exhibit activities in blocking induction of NMDA receptor-independe...

CAS 1303994-09-3 (RS)-MCPG Disodium Salt

(RS)-MCPG Disodium Salt
(CAS: 1303994-09-3)

(RS)-MCPG disodium salt is a non-selective group I/II metabotropic glutamate receptor antagonist.

CAS 67684-64-4 (±)-trans-ACPD

(CAS: 67684-64-4)

(±)-trans-ACPD has been found to be a mGluR2 agonist.

CAS 117857-93-9 L-CCG-l

(CAS: 117857-93-9)

L-CCG-l is a potent group II metabotropic glutamate receptor (mGluR) agonist.

CAS 169209-64-7 MSPG

(CAS: 169209-64-7)

MSPG is a non-selective antagonist of presynaptic mGluRs.

Chemical Structure

CAS 693288-97-0 CPPHA

Quick Inquiry

Verification code

Featured Items